Myriad Genetics, Inc. (MYGN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Myriad Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.136 Good day and thank you for standing by. Welcome to the Marriott Genetics First 00:00:05.136 -- 00:00:09.401 Quarter 2025 Financial Earnings Conference Call. 00:00:09.401 -- 00:00:12.944 At this time, all participants are in a listen-only mode. 00:00:12.944 -- 00:00:16.668 After the speaker's presentation, there will be a question and answer session. 00:00:16.668 -- 00:00:21.673 To ask a question during the session, you will need to press star 1-1 on your 00:00:21.673 -- 00:00:26.879 telephone. You will then hear an automated message advising your hand is raised. 00:00:26.879 -- 00:00:31.445 To withdraw your question, please press star 1-1 again. 00:00:31.445 -- 00:00:35.531 Please be advised that today's conference is being recorded. 00:00:35.531 -- 00:00:41.078 I would now like to hand the conference over to your speaker today, Matt Scallo, 00:00:41.078 -- 00:00:44.043 Senior Vice President of Investor Relations. 00:00:44.043 -- 00:00:46.683 Please go ahead. 00:00:47.585 -- 00:00:52.676 Good afternoon and welcome to the Myriad Genetics first quarter 2025 earnings 00:00:52.676 -- 00:00:57.768 call. During the call, we will review the financial results we released today and 00:00:57.768 -- 00:01:03.021 afterwards we will host a Q&A session. Our quarterly earnings release was issued this 00:01:03.021 -- 00:01:08.926 afternoon on form 8K and can be found on our website at investor.myriad.com. 00:01:09.309 -- 00:01:12.994 I'm Matt Scalo, Senior Vice President of Investor Relations. 00:01:12.994 -- 00:01:18.201 On the call with me today are Sam Raha, our President and Chief Executive Officer, 00:01:18.201 -- 00:01:23.407 Scott Loeffler, our Chief Financial Officer, and Mark Verratti, our Chief Operating 00:01:23.407 -- 00:01:29.849 Offi...